Trends of multimorbidity in 15 European countries: a population-based study in community-dwelling adults aged 50 and over
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
P01 AG005842
NIA NIH HHS - United States
R21 AG025169
NIA NIH HHS - United States
HHSN271201300071C
NIA NIH HHS - United States
PubMed
33413239
PubMed Central
PMC7792098
DOI
10.1186/s12889-020-10084-x
PII: 10.1186/s12889-020-10084-x
Knihovny.cz E-zdroje
- Klíčová slova
- Europe, Non-communicable diseases, Older adults, Prevalence, SHARE,
- MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- multimorbidita * MeSH
- samostatný způsob života * MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Geografické názvy
- Belgie MeSH
- Česká republika epidemiologie MeSH
- Evropa epidemiologie MeSH
- Francie MeSH
- Německo MeSH
- Nizozemsko MeSH
- Rakousko MeSH
- Španělsko MeSH
- Švýcarsko MeSH
BACKGROUND: The objective of this work was to analyse the prevalence trends of multimorbidity among European community-dwelling adults. METHODS: A temporal series study based on waves 1, 2, 4, 5, 6 and 7 of the Survey of Health, Ageing and Retirement in Europe (SHARE) was conducted, and community-dwelling participants aged 50+ (n = 274,614) from 15 European countries were selected for the period 2004-2017. Prevalence, adjusted by age, Average Annual Percentage Change (APC) and 95% confidence interval (95% CI) were all calculated. Trend analyses were realised by period, age groups and groups of diseases. RESULTS: The results showed a large variability in the prevalence of multimorbidity in adults aged 50 and over among European countries. Increase in the prevalence of multimorbidity in the countries of central Europe (Austria, Belgium, Czech Republic, France, Germany and Switzerland) and Spain in both sexes, and in the Netherlands among men. Stability was observed in northern and eastern European countries. Musculoskeletal and neurodegenerative groups showed more significant changes in the trend analyses. CONCLUSIONS: This information can be useful for policy makers when planning health promotion and prevention policies addressing modifiable risk factors in health.
Zobrazit více v PubMed
Murray CJL, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–2191. doi: 10.1016/S0140-6736(15)61340-X. PubMed DOI PMC
Le Reste JY, Nabbe P, Manceau B, et al. The European general practice research network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature. J Am Med Dir Assoc. 2013;14(5):319–325. doi: 10.1016/j.jamda.2013.01.001. PubMed DOI
Hopman P, Heins MJ, Korevaar JC, Rijken M, Schellevis FG. Health care utilization of patients with multiple chronic diseases in the Netherlands: differences and underlying factors. Eur J Intern Med. 2016;35:44–50. doi: 10.1016/j.ejim.2016.08.025. PubMed DOI
Salive ME. Multimorbidity in Older Adults. Epidemiol Rev. 2013;35(4):75–83. doi: 10.1093/epirev/mxs009. PubMed DOI
Dhalwani NN, O’Donovan G, Zaccardi F, et al. Long terms trends of multimorbidity and association with physical activity in older English population. Int J Behav Nutr Phys Act. 2016;13(1). 10.1186/s12966-016-0330-9. PubMed PMC
Van Oostrom SH, Gijsen R, Stirbu I, et al. Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys. PLoS One. 2016:1–14. 10.1371/journal.pone.0160264. PubMed PMC
Tacken MAJB, Opstelten W, Vossen I, et al. Increased multimorbidity in patients in general practice in the period 2003–2009. Ned Tijdschr Geneeskd. 2011;155(26):A3109. PubMed
Lai FTT, Guthrie B, Wong SY, et al. Sex-specific intergenerational trends in morbidity burden and multimorbidity status in Hong Kong community: an age-period-cohort analysis of repeated population surveys. BMJ Open. 2019. 10.1136/bmjopen-2018-023927. PubMed PMC
Uijen A, van de Lisdonk E. Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract. 2008;14(SUPPL. 1):28–32. doi: 10.1080/13814780802436093. PubMed DOI
SHARE project. Available: http://www.share-project.org. Accessed 10/03, 2020.
Börsch-Supan A. Survey of Health, Ageing and Retirement in Europe (SHARE) Wave 6. Release version: 6.0.0. SHARE-ERIC. Data set; 2017. 10.6103/SHARE.w6.600.
Börsch-Supan A, Jürges H. The survey of health, ageing and retirement in Europe – methodology. Mannheim: MEA; 2005. PubMed PMC
Hazewinkel M. Encyclopedia of mathematics, ISBN 978-1-55608-010-4. Netherlands: Springer; 2001. https://www.springer.com/gp/book/9781556080050.
Violan C, Foguet-Boreu Q, Flores-Mateo G, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One. 2014;9(7):3–11. doi: 10.1371/journal.pone.0102149. PubMed DOI PMC
Nielsen CR, Halling A, Andersen-Ranberg K. Disparities in multimorbidity across Europe – findings from the SHARE survey. Eur Geriatr Med. 2017;8(1):16–21. doi: 10.1016/j.eurger.2016.11.010. DOI
Hoffmann W, Diederichs CP, Ellert U, Bartels DB, Wellmann J, Berger K. How to weight chronic diseases in multimorbidity indices? Development of a new method on the basis of individual data from five population-based studies. J Clin Epidemiol. 2012;65(6):679–685. doi: 10.1016/j.jclinepi.2011.11.006. PubMed DOI
Holzer BM, Siebenhuener K, Bopp M, Minder CE. Evidence-based design recommendations for prevalence studies on multimorbidity: improving comparability of estimates. Popul Health Metr. 2017:1–9. 10.1186/s12963-017-0126-4. PubMed PMC
Johnston MC, Crilly M, Black C, Prescott GJ, Mercer SW. Systematic review and meta-analyses defining and measuring multimorbidity: a systematic review of systematic reviews. Eur J Public Health. 2018:1–7. 10.1093/eurpub/cky098. PubMed
Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases - A systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci. 2011;66(3):301–311. doi: 10.1093/gerona/glq208. PubMed DOI
Staehelin A, Gnädinger M, Ceschi A, et al. Chronic conditions and multimorbidity in a primary care population: a study in the Swiss sentinel surveillance network (Sentinella) Int J Public Health. 2018;63(9):1017–1026. doi: 10.1007/s00038-018-1114-6. PubMed DOI PMC
Guisado-Clavero M, Roso-Llorach A, López-Jimenez T, et al. Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis. BMC Geriatr. 2018;18(1):1–11. doi: 10.1186/s12877-018-0705-7. PubMed DOI PMC
Myint PK, Tay HS, Tay A, et al. Prevalence of multimorbidity and its association with outcomes in older emergency general surgical patients: an observational study. BMJ Open. 2016;6(3):e010126. doi: 10.1136/bmjopen-2015-010126. PubMed DOI PMC
Uijen AA, Lisdonk EH. Multimorbidity in primary care: Prevalence and trend over the last 20 years. Eur J Gen Pract. 2009;4788. 10.1080/13814780802436093. PubMed
Lebenbaum M, Zaric GS, Thind A, Sarma S. Trends in obesity and multimorbidity in Canada. Prev Med. 2018;116(February):173–179. doi: 10.1016/j.ypmed.2018.08.025. PubMed DOI
Kivimäki M, Kuosma E, Ferrie JE, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017;2(6):e277–e285. doi: 10.1016/S2468-2667(17)30074-9. PubMed DOI PMC
Peralta M, Ramos M, Lipert A, Martins J, Marques A. Prevalence and trends of overweight and obesity in older adults from 10 European countries from 2005 to 2013. Scand J Public Health. 2018;46(5):522–529. doi: 10.1177/1403494818764810. PubMed DOI
Niu H, Alvarez-Alvarez I, Guillen-Grima F, Al-Rahamneh MJ, Aguinaga-Ontoso I. Trends of mortality from Alzheimer’s disease in the European Union, 1994–2013. Eur J Neurol. 2017;24(6):858–866. doi: 10.1111/ene.13302. PubMed DOI
Minichiello É, Semerano L, Boissier M-C. Évolution dans le temps de la polyarthrite rhumatoïde: incidence, prévalence, gravité. Revue systématique de la littérature. Rev Rhum. 2016;84(1):9–16. doi: 10.1016/j.rhum.2016.05.015. DOI
Park J, Mendy A, Vieira ER. Various types of arthritis in the United States: prevalence and age-related trends from 1999 to 2014. Am J Public Health. 2018;108(2):256–258. doi: 10.2105/AJPH.2017.304179. PubMed DOI PMC
Jean S, Hudson M, Gamache P, et al. Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study. Clin Rheumatol. 2017;36(12):2667–2671. doi: 10.1007/s10067-017-3796-1. PubMed DOI
Myasoedova E, Davis JM, Achenbach SJ, Matteson EL, Crowson CS. Trends in prevalence of functional disability in rheumatoid arthritis compared with the general population. Mayo Clin Proc. 2019;94(6):1035–1039. doi: 10.1016/j.mayocp.2019.01.002. PubMed DOI PMC
De Carvalho JN, Roncalli ÂG, De Camargo CM, De Souza DLB. Prevalence of multimorbidity in the Brazilian adult population according to socioeconomic and demographic characteristics. PLoS One. 2017;12(4):1–13. doi: 10.1371/journal.pone.0174322. PubMed DOI PMC
Navickas R, Petric V-K, Feigl AB, Seychell M. Multimorbidity: what do we know? what should we do? J Comorbid. 2016;6(1):4–11. doi: 10.15256/joc.2016.6.72. PubMed DOI PMC
Chatterji S, Byles J, Cutler D, Seeman T, Verdes E. Health, functioning, and disability in older adults - present status and future implications. Lancet. 2015;385(9967):563–575. doi: 10.1016/S0140-6736(14)61462-8. PubMed DOI PMC
Malter F, Börsch-Supan A. SHARE wave 5: Innovations & Methodology. Munich: MEA, Max Planck Institute for Social Law and Social Policy; 2015.